Low Dose G-CSF to Augment Host Defense and Counteract Progression of Sepsis

Weiß, Manfred; Schneider, E. M.; Radermacher, Peter

doi:10.1007/978-3-642-80053-5_14

Yearbook of Intensive Care and Emergency Medicine

1996

DOI: 10.1007/978-3-642-80053-5_14

|View full text |Cite

Low Dose G-CSF to Augment Host Defense and Counteract Progression of Sepsis

Manfred Weiß¹,

E. M. Schneider²,

Peter Radermacher³

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

1998

1999

Publication Types

Select...

Article3

Relationship

Self Cite0

Independent3

Authors

Journals

Cited by 3 publications

References 49 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

Rekombinanter, humaner Granulozyten Kolonie-stimulierender Faktor (rhG-CSF) zur Therapie von Patienten mit SIRS oder Sepsis mit transienter bzw. persistierender Immundysfunktion (MARS, CARS)

Weiß¹,

Schneider

1998

Intensivmedizin und Notfallmedizin

View full text Add to dashboard Cite

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

hi@scite.ai

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Low Dose G-CSF to Augment Host Defense and Counteract Progression of Sepsis

Cited by 3 publications

References 49 publications

Rekombinanter, humaner Granulozyten Kolonie-stimulierender Faktor (rhG-CSF) zur Therapie von Patienten mit SIRS oder Sepsis mit transienter bzw. persistierender Immundysfunktion (MARS, CARS)

Rekombinanter, humaner Granulozyten Kolonie-stimulierender Faktor (rhG-CSF) zur Therapie von Patienten mit SIRS oder Sepsis mit transienter bzw. persistierender Immundysfunktion (MARS, CARS)

Granulocyte Colony-Stimulating Factor to Prevent the Progression of Systemic Nonresponsiveness in Systemic Inflammatory Response Syndrome and Sepsis

Granulocyte Colony-Stimulating Factor to Prevent the Progression of Systemic Nonresponsiveness in Systemic Inflammatory Response Syndrome and Sepsis

Contact Info

Product

Resources

About